Takeda Pharmaceutical
TAK
$14.62
Share price
-2.17%
Change (1 day)
5.29%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $54.36 B
According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are $54.36 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $57.07 B | -7.07% |
| 2022-03-31 | $61.41 B | -12.41% |
| 2021-03-31 | $70.12 B | -6.4% |
| 2020-03-31 | $74.91 B | -4.52% |
| 2019-03-31 | $78.46 B | 299.29% |
| 2018-03-31 | $19.65 B | -8.74% |
| 2017-03-31 | $21.53 B | 33.46% |
| 2016-03-31 | $16.13 B | -7.36% |
| 2015-03-31 | $17.41 B | -11.67% |
| 2014-03-31 | $19.71 B | 7.31% |
| 2013-03-31 | $18.37 B | 1.16% |
| 2012-03-31 | $18.16 B | 132.44% |
| 2011-03-31 | $7.81 B | 10.97% |
| 2010-03-31 | $7.04 B | -1.34% |
| 2009-03-31 | $7.13 B | 35.29% |
| 2008-03-31 | $5.27 B | 1.61% |
| 2007-03-31 | $5.19 B | -11.89% |
| 2006-03-31 | $5.89 B | 16.04% |
| 2005-03-31 | $5.07 B | -4.6% |
| 2004-03-31 | $5.32 B | 27.76% |
| 2003-03-31 | $4.16 B | 9.78% |
| 2002-03-31 | $3.79 B | -3.44% |
| 2001-03-31 | $3.92 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $115.27 B | 112.04% | 🇺🇸 USA |
 Novartis NVS | $59.04 B | 8.61% | 🇨🇭 Switzerland |
 Pfizer PFE | $120.87 B | 122.34% | 🇺🇸 USA |
 Amgen AMGN | $83.48 B | 53.57% | 🇺🇸 USA |
 Sanofi SNY | $56.95 B | 4.76% | 🇫🇷 France |
 Merck MRK | $65.72 B | 20.90% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $59.66 B | 9.76% | 🇬🇧 UK |
 Seagen
SGEN | $0.87 B | -98.39% | 🇺🇸 USA |
 Dr. Reddy's RDY | $1.09 B | -97.99% | 🇮🇳 India |